Felipe Couñago, Medical Director at GenesisCare Spain, shared a post on LinkedIn:
“Excited to be joining the faculty this week at the Summer School of Clinical Adaptive Radiotherapy on Uro-Oncology in Negrar, Italy.
The program brings together an exceptional panel of international experts, many of whom are among the world’s leading voices in adaptive radiotherapy, MR-guided radiotherapy, SBRT, and uro-oncology. It is truly an honour to be part of such an outstanding faculty.
I am particularly looking forward to participating in the debate:
‘Is there a place for the adaptive approach in bladder cancer treatment?’
Pro: Felipe Couñago
Contra: Ananya Choudury
Adaptive radiotherapy is rapidly transforming the management of genitourinary malignancies, and bladder cancer remains one of the most exciting frontiers for innovation, personalization, and precision treatment.
A special thank you to my good friends Filippo Alongi and Luca Nicosia for their invitation, leadership, and for assembling such a remarkable scientific program and faculty.
Looking forward to stimulating discussions, new ideas, hands-on learning, and reconnecting with colleagues and friends from across Europe and beyond.
See you in Negrar!”
Other articles featuring Felipe Couñago on OncoDaily.
